Index - P/E 23.89 EPS (ttm) 11.73 Insider Own 32.31% Shs Outstand 21.99M Perf Week -5.11%
Market Cap 7.59B Forward P/E 25.91 EPS next Y 10.82 Insider Trans -0.03% Shs Float 18.32M Perf Month -2.37%
Enterprise Value 7.62B PEG 4.69 EPS next Q 1.96 Inst Own 70.83% Short Float 5.47% Perf Quarter 20.62%
Income 319.17M P/S 2.97 EPS this Y -3.50% Inst Trans -1.01% Short Ratio 3.23 Perf Half Y 14.42%
Sales 2.55B P/B 1.06 EPS next Y 8.74% ROA 3.21% Short Interest 1.00M Perf YTD -14.66%
Book/sh 263.42 P/C 5.52 EPS next 5Y 5.09% ROE 4.59% 52W High 387.99 -27.75% Perf Year -13.53%
Cash/sh 50.80 P/FCF 20.47 EPS past 3/5Y - - ROIC 3.76% 52W Low 211.43 32.59% Perf 3Y -42.95%
Dividend Est. - EV/EBITDA 14.87 Sales past 3/5Y -4.24% 2.11%Gross Margin 53.52% Volatility 2.86% 2.72% Perf 5Y -42.11%
Dividend TTM - EV/Sales 2.98 EPS Y/Y TTM 125.03% Oper. Margin 12.35% ATR (14) 8.90 Perf 10Y 103.72%
Dividend Ex-Date - Quick Ratio 3.67 Sales Y/Y TTM -0.33% Profit Margin 12.50% RSI (14) 48.28 Recom 1.78
Dividend Gr. 3/5Y - - Current Ratio 5.12 EPS Q/Q 115.30% SMA20 -3.28% Beta 0.98 Target Price 332.00
Payout - Debt/Eq 0.20 Sales Q/Q 2.06% SMA50 3.30% Rel Volume 0.78 Prev Close 285.90
Employees 7700 LT Debt/Eq 0.19 Earnings Jul 31 AMC SMA200 1.10% Avg Volume 310.56K Price 280.34
IPO Feb 27, 1980 Option/Short Yes / Yes EPS/Sales Surpr. 50.52% 5.92% Trades
Volume 242,014 Change -1.94%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-01-24 Upgrade Citigroup
Neutral → Buy
$350 → $400
Aug-28-24 Initiated Wells Fargo
Equal Weight
$340
Jun-03-24 Resumed Jefferies
Hold
$315
Apr-03-24 Downgrade Citigroup
Buy → Neutral
$400 → $365
Dec-07-23 Initiated UBS
Buy
$395
Jun-16-23 Initiated Wells Fargo
Overweight
$550
Dec-07-22 Initiated RBC Capital Mkts
Outperform
$565
Aug-25-22 Initiated Credit Suisse
Outperform
$715
Jan-28-22 Reiterated Citigroup
Buy
$915 → $750
Jan-08-20 Initiated Wells Fargo
Overweight
$430
Jan-07-20 Initiated Citigroup
Buy
$450
Oct-17-18 Initiated Goldman
Buy
$350
Sep-20-18 Initiated Morgan Stanley
Equal-Weight
$335
Feb-16-18 Downgrade CL King
Buy → Neutral
Jul-13-17 Initiated Wells Fargo
Outperform
Jun-28-17 Upgrade Deutsche Bank
Hold → Buy
$220 → $255
Jan-18-17 Initiated Deutsche Bank
Hold
$195
Oct-13-16 Initiated CL King
Buy
May-06-15 Reiterated Jefferies
Buy
$150 → $165
Dec-18-09 Initiated Maxim Group
Buy
$125
Show Previous Ratings
Sep-02-25 08:23AM
Sep-01-25 10:17AM
Aug-22-25 07:47PM
(Morningstar Research) +6.59%
Aug-13-25 08:41AM
Aug-12-25 04:49AM
07:48AM
Loading…
Aug-02-25 07:48AM
Aug-01-25 12:31PM
(Morningstar Research) +17.63%
09:00AM
03:39AM
Jul-31-25 05:28PM
(Associated Press Finance)
04:15PM
Jul-30-25 09:28AM
05:08AM
Jul-29-25 10:00AM
04:31AM
04:02AM
Loading…
04:02AM
Jul-28-25 04:15PM
Jul-25-25 10:44PM
Jul-24-25 10:00AM
Jul-17-25 04:15PM
Jul-16-25 04:07AM
Jul-14-25 08:07AM
Jul-11-25 04:02AM
Jul-10-25 05:19AM
Jul-07-25 09:00AM
Jun-16-25 08:30AM
May-29-25 04:30PM
May-13-25 09:16AM
May-12-25 04:30PM
May-03-25 08:45AM
06:48PM
Loading…
May-02-25 06:48PM
07:58AM
May-01-25 10:35PM
05:40PM
04:15PM
Apr-29-25 12:59PM
Apr-24-25 10:35AM
10:25AM
10:01AM
Apr-23-25 06:00AM
Apr-22-25 08:09AM
Apr-21-25 08:08AM
Apr-15-25 09:50PM
04:15PM
Apr-13-25 12:48PM
09:51AM
Apr-10-25 01:29PM
(Morningstar Research) -6.77%
Apr-04-25 08:28PM
Apr-03-25 09:00AM
Mar-31-25 10:00AM
09:20AM
Mar-24-25 04:05PM
Mar-21-25 06:34AM
Mar-17-25 05:29PM
Feb-15-25 10:05AM
Feb-14-25 05:14PM
(Morningstar Research) -9.53%
12:07PM
Feb-13-25 04:20PM
04:15PM
Feb-11-25 08:46AM
Feb-10-25 08:30AM
Jan-27-25 05:00PM
Jan-08-25 08:15AM
Jan-02-25 04:30PM
Nov-24-24 08:05PM
Nov-21-24 09:00AM
Oct-31-24 11:52AM
(Morningstar Research) +8.35%
09:00AM
Oct-30-24 04:15PM
Oct-14-24 05:30PM
Sep-23-24 07:45AM
Sep-22-24 06:00AM
Sep-19-24 04:20PM
Sep-09-24 10:56AM
Sep-06-24 06:43PM
Aug-28-24 05:25PM
Aug-22-24 04:30PM
Aug-20-24 08:30AM
Aug-01-24 04:15PM
Jul-17-24 04:30PM
Jun-21-24 08:30AM
Jun-14-24 04:35AM
Jun-06-24 11:31AM
May-30-24 09:00AM
May-23-24 04:15PM
May-08-24 01:52PM
12:17PM
09:03AM
May-07-24 05:30PM
04:15PM
May-04-24 12:15AM
May-03-24 12:15PM
May-01-24 09:00AM
Apr-30-24 10:00AM
Apr-26-24 08:30AM
Apr-18-24 10:03AM
09:00AM
Apr-16-24 10:56AM
Apr-11-24 05:30PM
Apr-10-24 04:15PM
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
EVRAN SEDAT EVP, Global Supply Chain Sep 06 '25 Option Exercise 0.00 864 0 1,801 Sep 09 04:24 PM Lakkaraju Roop Kalyan EVP, Chief Financial Officer Sep 06 '25 Option Exercise 0.00 1,535 0 2,394 Sep 09 04:23 PM COREY COLLEEN EVP, Global Human Resources Sep 06 '25 Option Exercise 0.00 576 0 19,759 Sep 09 04:23 PM BARRY JAMES EVP, President, LSG Sep 06 '25 Option Exercise 0.00 1,056 0 1,588 Sep 09 04:22 PM Allison Schwartz Director Sep 06 '25 Option Exercise 0.00 92 0 1,489 Sep 09 04:21 PM ENGELHARDT EVA ANETTE EVP, President, CDG Sep 06 '25 Option Exercise 0.00 1,152 0 1,309 Sep 09 04:21 PM ENLOE COURTNEY C EVP, General Counsel & Sec Sep 06 '25 Option Exercise 0.00 768 0 904 Sep 09 04:20 PM SCHWARTZ NORMAN D Chairman & CEO Sep 06 '25 Option Exercise 0.00 3,455 0 444,962 Sep 09 04:19 PM Allison Schwartz Director Sep 01 '25 Option Exercise 0.00 147 0 1,452 Sep 03 06:03 PM BARRY JAMES EVP, President, LSG Sep 01 '25 Option Exercise 0.00 602 0 749 Sep 03 06:03 PM COREY COLLEEN EVP, Global Human Resources Sep 01 '25 Option Exercise 0.00 1,102 0 19,581 Sep 03 06:02 PM SCHWARTZ NORMAN D Chairman & CEO Sep 01 '25 Option Exercise 0.00 6,353 0 444,591 Sep 03 06:00 PM MICHAEL W CROWLEY Officer Aug 05 '25 Proposed Sale 275.92 1,488 410,572 Aug 05 04:47 PM ENGELHARDT EVA ANETTE EVP, President, CDG Jul 25 '25 Option Exercise 0.00 245 0 245 Jul 29 05:20 PM Lakkaraju Roop Kalyan EVP, Chief Financial Officer Apr 24 '25 Option Exercise 0.00 1,077 0 1,231 Apr 25 06:07 PM ENLOE COURTNEY C EVP, General Counsel & Sec Apr 24 '25 Option Exercise 0.00 186 0 196 Apr 25 06:06 PM PINKSTON ARNOLD A Director Apr 22 '25 Option Exercise 0.00 308 0 308 Apr 24 05:15 PM PEI MELINDA LITHERLAND Director Apr 22 '25 Option Exercise 0.00 308 0 308 Apr 24 05:14 PM HINCKLEY GREGORY K Director Apr 22 '25 Option Exercise 0.00 308 0 308 Apr 24 05:14 PM EDWARDS JEFFREY L Director Apr 22 '25 Option Exercise 0.00 308 0 308 Apr 24 05:13 PM Crowley Michael EVP, GBL Commercial Operations Mar 14 '25 Option Exercise 159.32 3,000 477,960 11,171 Mar 18 04:36 PM Crowley Michael EVP, GBL Commercial Operations Mar 14 '25 Sale 247.06 3,000 741,184 8,171 Mar 18 04:36 PM Crowley Michael Officer Mar 13 '25 Proposed Sale 260.00 3,000 780,000 Mar 13 05:17 PM Alles Institute for Medical Re Director Mar 11 '25 Proposed Sale 247.66 410 101,540 Mar 11 12:36 PM Last Andrew J. Officer Nov 06 '24 Proposed Sale 373.64 3,000 1,120,934 Nov 06 06:26 PM EVRAN SEDAT EVP, Global Supply Chain Oct 20 '24 Option Exercise 0.00 1,044 0 1,188 Oct 22 04:30 PM
